2
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Branhamella catarrhalis in Acute Otitis Media

, , , , , , & show all
Pages 285-290 | Published online: 08 Jul 2009

References

  • Grönroos J A, Kortekangas A E, Ojala L, Vuori M. The aetiology of acute middle ear infection. Acta Otolaryngol (Stockh) 1964; 58: 149
  • Coffey JD, Jr. Otitis media in the practice of pediatrics. Bacteriological and clinical observations. Pediatrics 1966; 38: 25
  • Coffey JD, Jr, Martin A D, Booth HN. Neisseria catarrhalis in exudate otitis media. Arch Otolaryngol 1967; 86: 69
  • Kamme C. Evaluation of the in vitro sensitivity of Neisseria catarrhalis to antibiotics with respect to acute otitis media. Scand J Infect Dis 1970; 2: 117
  • Howie V M, Ploussard J H, Lester RL. Otitis media: clinical and bacteriological correlation. Pediatrics 1970; 45: 29
  • Leinonen M, Loutonen J, Herva E, Valkonen K, Makela PH. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis 1981; 144: 570
  • Douglas R M, Miles H, Hansman D, Moore B, English DT. Microbiology of acute otitis media with particular reference to the feasibility of pneumococcal immunization. Med J Aust 1980; 1: 263
  • Luotonen J, Herva E, Karma P, Timonen M, Leinonen M, Mäkelä PH. The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis 1981; 13: 177
  • Kovatch A L, Wald E R, Michaels RH. β-lactamase-producing Branhamella catarrhalis causing otitis media in children. J Pediatr 1983; 102: 261
  • Shurin P A, Marchant C D, Kim C H, van Hare G F, Johnson C E, Tutihasi M A, Knapp LJ. Emergence of β-actamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. Pediatr Infect Dis 1983; 2: 34
  • Malmvall B-E, Brorson J-E, Johnsson J. In vitro sensitibity to penicillin V and β-lactamase production of Branhamella catarrhalis. J Antimicrob Chemother 1977; 3: 374
  • Ninane G, Joly J, Piot P, Kraytman M. Branhamella (Neisseria) catarrhalis as pathogen. Lancet 1977; ii: 149
  • Percival A, Corkill J E, Rowlands J, Sykes RB. Pathogenicity of and β-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet 1977; ii: 1175
  • Kamme C. Penicillintryck bor minskas vid ovre luftvagsinfektioner. Lakartidningen 1977; 79: 2697
  • Kallings I, Bengtsson S, Christensen P, Holm S E, Lind L, Kalin M. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden. Scand J Infect Dis 1983; 39: 100, Suppl.
  • Qvarnberg Y, Palva T. Active and conservative treatment of acute otitis media: Prospective studies. Ann Otol Rhinol Laryngol 1980; 89: 68, 269, Suppl.
  • Berger U. Die anspruchlosen Neisserien. Ergebn microbiol 1963; 36: 97
  • O'Callaghan C H, Morris A, Kirby S M, Shingler AH. Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283
  • McGhie D, Clarke P D, Johnson T, Hutchinson J GP. Detection of β-lactamase activity of Haemophilus influenzae. J Clin Pathol 1975; 30: 585
  • Klein JO. Microbiology of acute and chronic otitis media. Ann Otol Rhinol Laryngol 1981; 89: 98, Suppl. 68
  • Kallings LO. Bacteriological aspects of infections of the upper respiratory tract. Scand J Infect Dis 1983; 9, Suppl. 39
  • Forsgren A. 1983, Personal communication.
  • Karma P, Luotonen J, Pukander J, Sipila M, Herva E, Gronroos P. Haemophilus influenzae in acute otitis media. Acta Otolaryngol (Stockh) 1983; 95: 105
  • Kovatch A L, Wald E R, Michaels R H, Blatter M M, Reisinger K S, Wucher FP. Clinical profile of children with acute otitis media caused by Branhamella catarrhalis. Recent advances in otitis media with effusion, DJ Lim, CD Bluestone, JO Klein, JD Nelson. BC Decker Inc., Philadelphia 1984; 111–14
  • Kamme C. Penicillinresistenta Branhamella catarrhalis. Frekvens och lamplig terapi. Lakartidningen 1980; 77: 4858
  • Kamme C, Vang M, Stahl S. Transfer of β-lactamase production in Branhamella catarrhalis. Scand J Infect Dis 1983; 15: 225
  • Van Hoi-Dang A B, Bouguenec CB-L, Barthelemy M, Labia R. Novel β-lactamase from Branha-mella catarrhalis. Ann Microbiol (Inst Pasteur) 1978; 129B: 397
  • Saunders JR. Genetics and evolution of antibiotic resistance. Br Med Bull 1984; 40: 54
  • Doern G V, Siebers K G, Hallick L M, Morse SA. Antibiotic susceptibility of β-lactamase-produc-ing strains of Branhamella (Neisseria) catarrhalis. Antimicrob Agents Chemother 1980; 17: 24
  • Bluestone CD. Treatment of otitis media with effusion. Scand J Infect Dis 1983; 26, Suppl. 39
  • Shurin P A, Kim C H, Fulton D, Marchant CD. Susceptibility of β-lactamase-producing strains of Branhamella catarrhalis to selected, orally administered antimicrobial agents. Recent advances in otitis media with effusion, DJ Lim, CD Bluestone, JO Klein, JD Nelson. BC Decker Inc., Philadelphia 1984; 283–5
  • Wald E, Kovatch A, Rohn D, Lyons M, Michaels R. Antimicrobial susceptibility of β-lactamase-producing otic strains of Branhamella catarrhalis. Abstracts of the Third International Symposium on Recent Advances in Otitis Media with Effusion. Fort Lauderdale, Florida May, 1983; 37

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.